
Cancer research company founded by Penn scientists acquired in $2.1 billion deal
Capstan Therapeutics was acquired by AbbVie in $2.1 billion deal. Credit: Mehak Dhaliwal Capstan Therapeutics — a biotechnology company pioneered by Penn researchers — was acquired by AbbVie in $2.1 billion deal. Capstan, which specializes in CAR-T …